Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Argus Health
Accenture
Harvard Business School
Dow
Merck
Fish and Richardson
Deloitte
Johnson and Johnson
McKesson

Generated: August 18, 2017

DrugPatentWatch Database Preview

Serb Sa Company Profile

« Back to Dashboard

What is the competitive landscape for SERB SA, and when can generic versions of SERB SA drugs launch?

SERB SA has one approved drug.

There is one US patent protecting SERB SA drugs.

There are twelve patent family members on SERB SA drugs in nine countries.

Summary for Applicant: Serb Sa

Patents:1
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Serb Sa
CYANOKIT
hydroxocobalamin
INJECTABLE;INJECTION022041-001Apr 8, 2011RXYesYes► Subscribe► SubscribeY ► Subscribe
Serb Sa
CYANOKIT
hydroxocobalamin
INJECTABLE;INJECTION022041-002Dec 15, 2006DISCNNoNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Serb Sa

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Serb Sa
CYANOKIT
hydroxocobalamin
INJECTABLE;INJECTION022041-002Dec 15, 2006► Subscribe► Subscribe
Serb Sa
CYANOKIT
hydroxocobalamin
INJECTABLE;INJECTION022041-001Apr 8, 2011► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Serb Sa Drugs

Country Document Number Estimated Expiration
Iceland4387► Subscribe
European Patent Office0775485► Subscribe
Norway315495► Subscribe
Australia7172096► Subscribe
JapanH09136837► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Fuji
Chinese Patent Office
McKesson
Citi
Johnson and Johnson
US Department of Justice
Accenture
Covington
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot